GFM1
Elongation factor G, mitochondrial
Also known as: EFGM, EFGM_HUMAN, EGF1, GFM, mtEF-G1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96RP9
- Gene
- GFM1
- Ensembl
- ENSG00000168827
- Chromosome
- 3
- Canonical length
- 751 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mitochondria
OverviewNCBI Gene
Eukaryotes contain two protein translational systems, one in the cytoplasm and one in the mitochondria. Mitochondrial translation is crucial for maintaining mitochondrial function and mutations in this system lead to a breakdown in the respiratory chain-oxidative phosphorylation system and to impaired maintenance of mitochondrial DNA. This gene encodes one of the mitochondrial translation elongation factors. Its role in the regulation of normal mitochondrial function and in different disease states attributed to mitochondrial dysfunction is not known. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
751 residues, UniProt reviewed canonical sequence.
>Q96RP9|GFM1
1 MRLLGAAAVA ALGRGRAPAS LGWQRKQVNW KACRWSSSGV IPNEKIRNIG ISAHIDSGKT
61 TLTERVLYYT GRIAKMHEVK GKDGVGAVMD SMELERQRGI TIQSAATYTM WKDVNINIID
121 TPGHVDFTIE VERALRVLDG AVLVLCAVGG VQCQTMTVNR QMKRYNVPFL TFINKLDRMG
181 SNPARALQQM RSKLNHNAAF MQIPMGLEGN FKGIVDLIEE RAIYFDGDFG QIVRYGEIPA
241 ELRAAATDHR QELIECVANS DEQLGEMFLE EKIPSISDLK LAIRRATLKR SFTPVFLGSA
301 LKNKGVQPLL DAVLEYLPNP SEVQNYAILN KEDDSKEKTK ILMNSSRDNS HPFVGLAFKL
361 EVGRFGQLTY VRSYQGELKK GDTIYNTRTR KKVRLQRLAR MHADMMEDVE EVYAGDICAL
421 FGIDCASGDT FTDKANSGLS MESIHVPDPV ISIAMKPSNK NDLEKFSKGI GRFTREDPTF
481 KVYFDTENKE TVISGMGELH LEIYAQRLER EYGCPCITGK PKVAFRETIT APVPFDFTHK
541 KQSGGAGQYG KVIGVLEPLD PEDYTKLEFS DETFGSNIPK QFVPAVEKGF LDACEKGPLS
601 GHKLSGLRFV LQDGAHHMVD SNEISFIRAG EGALKQALAN ATLCILEPIM AVEVVAPNEF
661 QGQVIAGINR RHGVITGQDG VEDYFTLYAD VPLNDMFGYS TELRSCTEGK GEYTMEYSRY
721 QPCLPSTQED VINKYLEATG QLPVKKGKAK NLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GFM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 59 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 59 nTPM
- tongue: 56 nTPM
- liver: 46 nTPM
- retina: 43 nTPM
- kidney: 41 nTPM
- parathyroid gland: 38 nTPM
Single-cell type
- epicardial cells: 314 nCPM
- mesothelial cells: 100 nCPM
- hepatocytes: 84 nCPM
- retinal bipolar cells: 82 nCPM
- retinal amacrine cells: 81 nCPM
- rod photoreceptor cells: 76 nCPM
Immune cell
- MAIT T-cell: 29 nTPM
- intermediate monocyte: 27 nTPM
- NK-cell: 26 nTPM
- naive CD8 T-cell: 24 nTPM
- myeloid DC: 23 nTPM
- memory CD8 T-cell: 23 nTPM
Brain region
- cerebellum: 40 nTPM
- choroid plexus: 38 nTPM
- cerebral cortex: 37 nTPM
- hypothalamus: 35 nTPM
- pons: 34 nTPM
- white matter: 34 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GFM1.
Disease | AllUniProt
Conditions GFM1 is implicated in, by any mechanism.
- Combined oxidative phosphorylation deficiency 1 (COXPD1) MIM:609060
Disease | GeneticClinVar
202 pathogenic / likely-pathogenic of 1,007 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.8
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.28
- DepMap mean gene effect
- -0.42
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 14% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Elongation factor EFG, domain V-like
- Translational (tr)-type GTP-binding domain
- Translation elongation factor EFTu-like, domain 2
- Small GTP-binding domain
- Translation elongation factor EFG/EF2, domain IV
- Translation protein, beta-barrel domain superfamily
- Elongation factor G, domain III
- Small ribosomal subunit protein uS5 domain 2-type fold, subgroup
- Ribosomal protein uS5 domain 2-type superfamily
- P-loop containing nucleoside triphosphate hydrolase
- Tr-type G domain, conserved site
- EF-G domain III/V-like
- EFG, domain V
- Elongation Factor G, domain II
- Elongation factor Tu GTP binding domain
- Elongation factor G C-terminus
- Elongation factor Tu domain 2
- Elongation factor G, domain IV
- Elongation Factor G, domain III
- Translation elongation factor EFG/EF2
- Elongation factor G, domain IV
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GFM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GFM1 as an antibody target. Whether an autoantibody or antibody against GFM1 could matter depends on whether native GFM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GFM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GFM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...